See What HealthDay Can Do For You
Contact Us

Stop-Smoking Program Effective in Psychotic Patients

Program increased rates of smoking cessation, smoking reduction

THURSDAY, Nov. 2 (HealthDay News) -- A stop-smoking program is effective for smoking cessation and smoking reduction in individuals with a psychotic disorder, according to the results of a study published in the November issue of the American Journal of Psychiatry.

Amanda Baker, Ph.D., from the University of Newcastle in Callaghan, Australia, and colleagues examined the effectiveness of a smoking-cessation program in 298 regular smokers with a psychotic disorder. Patients were randomly assigned to either routine care or an eight-week stop-smoking program consisting of nicotine replacement therapy, cognitive behavior therapy and motivational interviewing.

The researchers found that significantly more patients who completed the smoking-cessation program had stopped smoking after three months (30 percent versus 6 percent), which continued for up to 12 months (18.6 percent versus 6.6 percent). The program also led to a reduction of at least 50 percent in daily cigarette consumption compared with a less than 20 percent reduction in those in the routine care group.

"These findings demonstrate the utility of a nicotine replacement therapy plus motivational interviewing/cognitive behavior therapy smoking cessation intervention among individuals with a psychotic disorder," the authors conclude.

GlaxoSmithKline provided nicotine replacement therapy for the study.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.